The trademark application APEXNK was filed by Apexcella Biomedical Inc., a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). The application was published for oppositions on March 26, 2023, and it was registered by office on July 3, 2023 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and address of the trademark registration was recorded on August 18, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Immunostimulants
Cells for medical use
Biological tissue cultures for medical purposes
Anticancer preparations
Medicines for human purposes
Pharmaceutical preparations and substances
Antiviral preparations
Biological preparations for medical purposes
Biocides
Chemical preparations for medical purposes
Blood for medical purposes
Chemico-pharmaceutical preparations
Adjuvants for medical purposes
Albuminous preparations for medical purposes
Chemical preparations for pharmaceutical purposes
Pharmaceutical drugs
Pharmaceutical preparations
Stem cells for medical purposes
Biological reagents for medical use
Diagnostic biomarker reagents for medical purposes.
The mark was filed in class 42 with following description of goods:
Biological research
Conducting of quality control tests
Clinical trials
Advisory services relating to chemical reagents
Medical research
Research and development services
Research and development of new products for others
Conducting technical project studies
Technical writing
Scientific laboratory services
Technological consultancy
Technological research
Scientific research
Culturing of cells for scientific research purposes